vs

Side-by-side financial comparison of Energy Recovery, Inc. (ERII) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.

Energy Recovery, Inc. is the larger business by last-quarter revenue ($66.9M vs $57.3M, roughly 1.2× RHYTHM PHARMACEUTICALS, INC.). Energy Recovery, Inc. runs the higher net margin — 40.2% vs -83.0%, a 123.2% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -0.3%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs 8.1%).

Energy Recovery Inc. is an American manufacturer of energy recovery devices for water and CO2 refrigeration industries.

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

ERII vs RYTM — Head-to-Head

Bigger by revenue
ERII
ERII
1.2× larger
ERII
$66.9M
$57.3M
RYTM
Growing faster (revenue YoY)
RYTM
RYTM
+37.2% gap
RYTM
36.9%
-0.3%
ERII
Higher net margin
ERII
ERII
123.2% more per $
ERII
40.2%
-83.0%
RYTM
Faster 2-yr revenue CAGR
RYTM
RYTM
Annualised
RYTM
48.5%
8.1%
ERII

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ERII
ERII
RYTM
RYTM
Revenue
$66.9M
$57.3M
Net Profit
$26.9M
$-47.5M
Gross Margin
67.2%
91.6%
Operating Margin
46.8%
-82.2%
Net Margin
40.2%
-83.0%
Revenue YoY
-0.3%
36.9%
Net Profit YoY
14.7%
-9.6%
EPS (diluted)
$0.49
$-0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ERII
ERII
RYTM
RYTM
Q4 25
$66.9M
$57.3M
Q3 25
$32.0M
$51.3M
Q2 25
$28.1M
$48.5M
Q1 25
$32.7M
Q4 24
$67.1M
$41.8M
Q3 24
$38.6M
$33.3M
Q2 24
$27.2M
$29.1M
Q1 24
$12.1M
$26.0M
Net Profit
ERII
ERII
RYTM
RYTM
Q4 25
$26.9M
$-47.5M
Q3 25
$3.9M
$-52.9M
Q2 25
$2.1M
$-46.6M
Q1 25
$-49.5M
Q4 24
$23.5M
$-43.3M
Q3 24
$8.5M
$-43.6M
Q2 24
$-642.0K
$-32.3M
Q1 24
$-8.3M
$-141.4M
Gross Margin
ERII
ERII
RYTM
RYTM
Q4 25
67.2%
91.6%
Q3 25
64.2%
89.3%
Q2 25
64.0%
88.6%
Q1 25
88.8%
Q4 24
70.2%
90.9%
Q3 24
65.1%
88.5%
Q2 24
64.6%
89.9%
Q1 24
59.0%
89.2%
Operating Margin
ERII
ERII
RYTM
RYTM
Q4 25
46.8%
-82.2%
Q3 25
11.4%
-102.6%
Q2 25
5.3%
-93.4%
Q1 25
-143.7%
Q4 24
38.2%
-98.6%
Q3 24
18.3%
-132.0%
Q2 24
-7.4%
-139.2%
Q1 24
-90.4%
-538.7%
Net Margin
ERII
ERII
RYTM
RYTM
Q4 25
40.2%
-83.0%
Q3 25
12.1%
-103.1%
Q2 25
7.3%
-96.1%
Q1 25
-151.4%
Q4 24
35.0%
-103.6%
Q3 24
22.0%
-131.2%
Q2 24
-2.4%
-110.9%
Q1 24
-68.3%
-544.4%
EPS (diluted)
ERII
ERII
RYTM
RYTM
Q4 25
$0.49
$-0.73
Q3 25
$0.07
$-0.82
Q2 25
$0.04
$-0.75
Q1 25
$-0.81
Q4 24
$0.40
$-0.71
Q3 24
$0.15
$-0.73
Q2 24
$-0.01
$-0.55
Q1 24
$-0.14
$-2.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ERII
ERII
RYTM
RYTM
Cash + ST InvestmentsLiquidity on hand
$75.2M
$388.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$206.2M
$139.1M
Total Assets
$231.5M
$480.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ERII
ERII
RYTM
RYTM
Q4 25
$75.2M
$388.9M
Q3 25
$70.4M
$416.1M
Q2 25
$79.5M
$291.0M
Q1 25
$314.5M
Q4 24
$78.0M
$320.6M
Q3 24
$118.6M
$298.4M
Q2 24
$101.0M
$319.1M
Q1 24
$117.4M
$201.2M
Stockholders' Equity
ERII
ERII
RYTM
RYTM
Q4 25
$206.2M
$139.1M
Q3 25
$180.8M
$148.8M
Q2 25
$185.2M
$-11.9M
Q1 25
$18.9M
Q4 24
$210.0M
$21.7M
Q3 24
$233.9M
$11.2M
Q2 24
$218.5M
$39.3M
Q1 24
$216.0M
$61.6M
Total Assets
ERII
ERII
RYTM
RYTM
Q4 25
$231.5M
$480.2M
Q3 25
$209.6M
$506.9M
Q2 25
$212.3M
$372.7M
Q1 25
$386.7M
Q4 24
$242.8M
$392.3M
Q3 24
$262.7M
$363.6M
Q2 24
$249.0M
$381.8M
Q1 24
$244.3M
$258.7M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ERII
ERII
RYTM
RYTM
Operating Cash FlowLast quarter
$7.1M
$-25.4M
Free Cash FlowOCF − Capex
$6.4M
FCF MarginFCF / Revenue
9.6%
Capex IntensityCapex / Revenue
1.0%
Cash ConversionOCF / Net Profit
0.26×
TTM Free Cash FlowTrailing 4 quarters
$15.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ERII
ERII
RYTM
RYTM
Q4 25
$7.1M
$-25.4M
Q3 25
$-3.1M
$-26.6M
Q2 25
$4.1M
$-23.3M
Q1 25
$-40.4M
Q4 24
$9.0M
$-18.8M
Q3 24
$-3.0M
$-25.2M
Q2 24
$8.1M
$-29.1M
Q1 24
$6.5M
$-40.7M
Free Cash Flow
ERII
ERII
RYTM
RYTM
Q4 25
$6.4M
Q3 25
$-3.5M
Q2 25
$4.0M
Q1 25
Q4 24
$8.9M
Q3 24
$-3.2M
Q2 24
$7.9M
Q1 24
$5.7M
FCF Margin
ERII
ERII
RYTM
RYTM
Q4 25
9.6%
Q3 25
-10.9%
Q2 25
14.3%
Q1 25
Q4 24
13.2%
Q3 24
-8.2%
Q2 24
28.9%
Q1 24
46.9%
Capex Intensity
ERII
ERII
RYTM
RYTM
Q4 25
1.0%
Q3 25
1.1%
Q2 25
0.5%
Q1 25
Q4 24
0.2%
Q3 24
0.4%
Q2 24
0.7%
Q1 24
6.8%
Cash Conversion
ERII
ERII
RYTM
RYTM
Q4 25
0.26×
Q3 25
-0.81×
Q2 25
2.02×
Q1 25
Q4 24
0.38×
Q3 24
-0.35×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ERII
ERII

Water Segment$38.6M58%
Other$11.0M16%
Original Equipment Manufacturer$10.6M16%
Aftermarket$6.6M10%

RYTM
RYTM

Segment breakdown not available.

Related Comparisons